News
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, announced today a poster presentation of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback